Each Friday over the summer, 7NEWS is live from a different town to show off all it has to offer! During each stop, Fred Cunningham will introduce you to the heroic first responders in your community ...

Editor’s Note — March 2026: We’ve updated our story to make sure items are in stock and available, plus we added a new best overall, the Goal Zero 1500 power station, a new model we recently reviewed, ...

Abstract: Deep learning-based synthetic aperture radar (SAR) target recognition often suffers from sparsely distributed training samples and rapid angular variations due to scattering scintillation.

Generate:Biomedicines has hit the public markets as the world begins to question the usefulness of AI technology. CEO Mike Nally says biology is the key to unlocking the technology’s full potential.

US biotech Generate Biomedicines (Nasdaq: GENB) raised $400 million in its initial public offering, selling 25 million shares at $16 each, the midpoint of its range. It marks the largest biotech IPO ...